AKT1 and prostate carcinoma: In our earlier reports, we have shown that silencing Epac1 expression by RNAi significantly suppresses proliferation of prostate cancer cells and down regulates the expression of signaling components of the MAPK and PI 3-kinase-Akt-mTOR signaling pathways [47], [48].